Zastaprazan

DB21524InvestigationalSmall molecule

Zastaprazan is a small molecule drug. The usage of the INN stem '-prazan' in the name indicates that Zastaprazan is a proton pump inhibitor, not dependent on acid activation. Zastaprazan... Zastaprazan is under investigation in clinical trial NCT05814809 (Clinical Trial to Evaluate the Safety and Pharmacokinetics of JP-1366 in Healthy Adult Volunteers).

Mechanism: Pharmacologically active on Potassium-transporting ATPase alpha chain 1
Curator reviewed
Formula / weight: C₂₂H₂₆N₄O · 362.477 g/mol (avg)
Code names: JP-1366

Resolves to

Compound

UNIIW9S9KZX5MDCAS2133852-18-1

Structure

InChIKeyFEQFUBYYZYQTOJ-UHFFFAOYSA-NSMILESCC1=C(C)N2C=C(C=C(NCC3=C(C)C=CC=C3C)C2=N1)C(=O)N1CCC1

Targets

P20648ATP4A

What you can answer from here — as of August 31, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

16Clinical trialsPhase, status and sponsor resolved per trial

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with Zastaprazan, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account